Pharmaceutical care: "Why do not we move forward? What is your solution?"

被引：0

|

作者：

Marti, Merce ^{[1
]}

机构：

[1] Fdn Pharmaceut Care, Madrid, Spain

来源：

PHARMACEUTICAL CARE ESPANA | 2011年 / 13卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：159 / 159

页数：1

相关论文

共 50 条

[21] Why Do We Do, What We Do?
Winter, Stacy
Collins, Dave
JOURNAL OF APPLIED SPORT PSYCHOLOGY, 2015, 27 (01) : 35 - 51
[22] Why do we do what we do?
Jenkins, L
JOURNAL OF HISTOTECHNOLOGY, 2005, 28 (02) : 53 - 53
[23] WHY DO WE DO WHAT WE DO
MACE, R
TRENDS IN ECOLOGY & EVOLUTION, 1995, 10 (01) : 4 - 5
[24] WHY DO WE DO WHAT WE DO?
Baker, Kathy A.
GASTROENTEROLOGY NURSING, 2015, 38 (06) : 405 - 406
[25] Postprandial hyperglycemia: Why do we care about it? What should we do?
Rendell, Marc S.
DRUG DEVELOPMENT RESEARCH, 2006, 67 (07) : 582 - 586
[26] Why Do Promising Therapies Stall in Development and How Can We Move Them Forward?
Wegner, Craig D.
Goodwin, Andrew
Cook, Jon C.
Allamneni, Krishna
Sohn, Jane
McVean, Maralee
INTERNATIONAL JOURNAL OF TOXICOLOGY, 2017, 36 (04) : 340 - 349
[27] Continuity of care: why it matters and what we can do
Hofer, Alexandra
McDonald, Malcolm
AUSTRALIAN JOURNAL OF PRIMARY HEALTH, 2019, 25 (03) : 214 - 218
[28] What is "global governance," anyway, and why do we care?
Weiss, Thomas G.
CANADIAN FOREIGN POLICY, 2013, 19 (03): : 263 - 265
[29] WHAT WE DO AND WHY
CREAGER, JG
AMERICAN BIOLOGY TEACHER, 1975, 37 (06): : 335 - 335
[30] Why we do what we do [5]
Fish, Peter
Design Engineering (Toronto), 2002, 48 (07):

← 1 2 3 4 5 →